Good Health is vital to all of us, and finding sustainable solutions to the health care challenges of our world cannot wait. That’s why we at Longmen are committed to developing and manufacturing qualified and stable bulk substance for pharmaceutical factory.
Luoyang Longmen Pharmaceutical Co., Ltd was used to be Yanshi Lactate Limited Company, which was founded in 1969. It is a pharmaceutical company mainly engaged in APIs including pharmaceutical grade calcium lactate, calcium hydrogen phosphate, sodium lactate solution and lactic acid etc,. In order to provide high-quality and large-quantity products, meet requirements of customer, the plant was moved into Luoning Industrial Park. Reconstruction of the new building has been finished in 2014. The area of the new plant was 30000 square meters, and fixed assets was ninety six million Yuan(RMB). The new factory was designed and established according to GMP 2010, and also passed GMP 2015. The factory was clean, tidy , ample and beautiful. Four production lines are generally independent of each other,which can prevent cross contamination. Equipment and facilities are good and qualified. Yearly output can reach fifteen thousand tons, which can meet needs of our customers at home and abroad.
With many years of experience in this field, Longmen is not only a lactate manufacturer, but also a responsible enterprise with full regards of people’s health and environmental protection. Luoyang Longmeng Pharmaceutical Co., Ltd is now standing at new historical starting points and marching toward to new target. With principle of ‘Quality, Customer, Standard and Honesty’, Longmen people promise our products will completely meet international standards and our service will fully meet each customer’s requirements.
Year of Establishment:
1969
Total Assets(USD):
choose not to disclose
Total Number of Staff:
less than 10 person
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
R&D capacity:
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Other Competitive Advantages:
Patents and Copyrights:
Two years of qualification
Audited Supplier
Pharma Sources Insight JANUARY 2024
